Siloxane polymer, siloxane polymer composition, and molded article

US12565586B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12565586-B2
Application numberUS-202118016859-A
CountryUS
Kind codeB2
Filing dateJul 29, 2021
Priority dateAug 6, 2020
Publication dateMar 3, 2026
Grant dateMar 3, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A siloxane polymer contains a silsesquioxane unit and a linear siloxane unit in its main chain and has a cage-type silsesquioxane structure in its side chain. A highly transparent and flexible film having a small linear thermal expansion coefficient is produced by utilizing the cohesion force (physical crosslinking) of the cage-type silsesquioxane in the side chain. The siloxane polymer has repeating units respectively represented by formulae (1) and (4), and has terminal groups respectively represented by formulae (5L) and (5R) at its right and left terminals, wherein A represents a structure shown below.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A siloxane polymer, having repeating units represented by Formulae (1) and (4) and terminal groups represented by Formulae (5L) and (5R) at left and right terminals: wherein Formula (5L) represents a terminal group bonded to a left side of the formula, and Formula (5R) represents a terminal group bonded to a right side of the formula, A represents the following structure, each R 0 independently represents an aryl group having 6 to 20 carbons or a cycloalkyl group having 5 to 6 carbons, and in the aryl group having 6 to 20 carbons and the cycloalkyl group having 5 to 6 carbons, arbitrary hydrogen atom may be independently substituted with a fluorine atom or an alkyl group having 1 to 20 carbons, each R 1 independently represents a hydrogen atom, an aryl group having 6 to 20 carbons, a cycloalkyl group having 5 to 6 carbons, an arylalkyl group having 7 to 40 carbons, or an alkyl group having 1 to 40 carbons, and in the aryl group in the aryl group having 6 to 20 carbons, the cycloalkyl group having 5 to 6 carbons and the arylalkyl group having 7 to 40 carbons, arbitrary hydrogen atom may be independently substituted with a fluorine atom or an alkyl group having 1 to 20 carbons, and in an alkylene group in the arylalkyl group having 7 to 40 carbons, arbitrary hydrogen atom may be substituted with a fluorine atom, and arbitrary —CH 2 — may be independently substituted with —O—, —CH═CH—, or a cycloalkylene group having 5 to 20 carbons, and in the alkyl group having 1 to 40 carbons, arbitrary hydrogen atom may be independently substituted with a fluorine atom, and arbitrary —CH 2 — may be independently substituted with —O— or a cycloalkylene group having 5 to 20 carbons, each R 2 independently represents a hydroxyl group, an aryl group having 6 to 20 carbons, a cycloalkyl group having 5 to 6 carbons, an arylalkyl group having 7 to 40 carbons, or an alkyl group having 1 to 40 carbons, and in the aryl group having 6 to 20 carbons, the cycloalkyl group having 5 to 6 carbons and an aryl group in the arylalkyl group having 7 to 40 carbons, arbitrary hydrogen atom may be independently substituted with a fluorine atom or an alkyl group having 1 to 20 carbons, and in an alkylene group in the arylalkyl group having 7 to 40 carbons, arbitrary hydrogen atom may be substituted with a fluorine atom, and arbitrary —CH 2 — may be independently substituted with —O—, —CH═CH—, or a cycloalkylene group having 5 to 20 carbons, and in the alkyl group having 1 to 40 carbons, arbitrary hydrogen atom may be independently substituted with a fluorine atom, and arbitrary —CH 2 — may be independently substituted with —O— or a cycloalkylene group having 5 to 20 carbons, each R 3 independently represents an alkylene group having 1 to 40 carbons, and in the alkylene group having 1 to 40 carbons, arbitrary —CH 2 — may be independently substituted with —O— or a cycloalkylene group having 5 to 20 carbons, each R 4 independently represents an aryl group having 6 to 20 carbons, a cycloalkyl group having 5 to 6 carbons, an arylalkyl group having 7 to 40 carbons, or an alkyl group having 1 to 40 carbons, and in the aryl group having 6 to 20 carbons, the cycloalkyl group having 5 to 6 carbons and an aryl group in the arylalkyl group having 7 to 40 carbons, arbitrary hydrogen atom may be independently substituted with a fluorine atom or an alkyl group having 1 to 20 carbons, and in an alkylene group in the arylalkyl group having 7 to 40 carbons, arbitrary hydrogen atom may be substituted with a fluorine atom, and arbitrary —CH 2 — may be independently substituted with —O—, —CH═CH—, or a cycloalkylene group having 5 to 20 carbons, and in the alkyl group having 1 to 40 carbons, arbitrary hydrogen atom may be independently substituted with a fluorine atom, and arbitrary —CH 2 — may be independently substituted with —O— or a cycloalkylene group having 5 to 20 carbons, each R 5 independently represents a crosslinkable functional group which is a hydroxyl group, hydrogen or an alkenyl group having 2 to 40 carbons, an alkyl group having 1 to 40 carbons, a halogen atom, an acyl group having 1 to 15 carbons, an alkoxyl group having 1 to 15 carbons, an oxime having 1 to 15 carbons, an amino group which may have a substituent, an amide having 1 to 15 carbons which may have a substituent, an aminoxy group which may have a substituent, or a vinyl alcohol residue having 2 to 15 carbons which may have a substituent, and in the amino and aminoxy groups which have a substituent, the substituent has 1 to 15 carbons, each p independently represents a real number of 1 or more, and z represents a positive real number, and * indicates a binding position. 2 . The siloxane polymer of claim 1 , further comprising repeating unit(s) represented by Formula (2) and/or (3): wherein R 2 represents the same as R 2 in Formula (4) in claim 1 , and x and y each independently represent a positive real number. 3 . The siloxane polymer of claim 1 , comprising repeating unit(s) represented by Formula (2+4) and/or (4+2): wherein R 2 represents the same as R 2 in Formula (4) in claim 1 , and x and z each independently represent a positive real number. 4 . The siloxane polymer of claim 1 , comprising at least one selected from the group consisting of repeating units represented by Formula (4+2+3), (2+4+3), (2+3+4), (4+3+2), (3+4+2) and (3+2+4): wherein R 2 represents the same as R 2 in Formula (4) in claim 1 , and x, y and z each independently represent a positive real number. 5 . The siloxane polymer of claim 1 , wherein each R 2 independently represents methyl or phenyl, and each R 4 independently represents phenyl, isobutyl, cyclopentyl, cyclohexyl, trifluoropropyl, nonafluorohexyl or pentafluorophenyl. 6 . The siloxane polymer of claim 1 , which has a weight average molecular weight of 2,000 to 10,000,000. 7 . A siloxane polymer composition, comprising: the siloxane polymer of claim 1 , and a solvent. 8 . A molded article, obtained by curing the siloxane polymer of claim 1 . 9 . The molded article of claim 8 , which has a haze value of 1% or less, a thermal decomposition temperature in a range of 350 to 450° C., and a coefficient of linear expansion of 200 ppm or less. 10 . The molded article of claim 8 , which has electric insulation. 11 . A molded article, comprising: a cured product obtained by curing the siloxane polymer of claim 1 , and a base covered by the cured product. 12 . The molded article of claim 11 , which has a coefficient of linear expansion of 200 ppm or less, wherein a difference in haze value between the molded article and the base is 1% or less. 13 . The molded article of claim 11 , which has electric insulation. 14 . A molded article, obtained by curing the siloxane polymer composition of claim 7 . 15 . The molded article of claim 14 , which has a haze value of 1% or less, a thermal decomposition temperature in a range of 350 to 450° C., and a coefficient of linear

Assignees

Inventors

Classifications

  • Block- or graft-copolymers containing polysiloxane sequences (obtained by polymerising a compound having a carbon-to-carbon double bond on to a polysiloxane C08L51/08, C08L53/00) · CPC title

  • containing halogens · CPC title

  • C08G77/24Primary

    halogen-containing groups · CPC title

  • use in electrical or conductive gadgets · CPC title

  • used for films · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12565586B2 cover?
A siloxane polymer contains a silsesquioxane unit and a linear siloxane unit in its main chain and has a cage-type silsesquioxane structure in its side chain. A highly transparent and flexible film having a small linear thermal expansion coefficient is produced by utilizing the cohesion force (physical crosslinking) of the cage-type silsesquioxane in the side chain. The siloxane polymer has rep…
Who is the assignee on this patent?
Jnc Corp
What technology area does this patent fall under?
Primary CPC classification C08G77/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).